398 related articles for article (PubMed ID: 33102583)
21. MicroRNA-145 Protects against Myocardial Ischemia Reperfusion Injury via CaMKII-Mediated Antiapoptotic and Anti-Inflammatory Pathways.
Liu Z; Tao B; Fan S; Pu Y; Xia H; Xu L
Oxid Med Cell Longev; 2019; 2019():8948657. PubMed ID: 31583047
[TBL] [Abstract][Full Text] [Related]
22. Novel CaMKII-δ Inhibitor Hesperadin Exerts Dual Functions to Ameliorate Cardiac Ischemia/Reperfusion Injury and Inhibit Tumor Growth.
Zhang J; Liang R; Wang K; Zhang W; Zhang M; Jin L; Xie P; Zheng W; Shang H; Hu Q; Li J; Chen G; Wu F; Lan F; Wang L; Wang SQ; Li Y; Zhang Y; Liu J; Lv F; Hu X; Xiao RP; Lei X; Zhang Y
Circulation; 2022 Apr; 145(15):1154-1168. PubMed ID: 35317609
[TBL] [Abstract][Full Text] [Related]
23. Asiatic Acid Alleviates Myocardial Ischemia-Reperfusion Injury by Inhibiting the ROS-Mediated Mitochondria-Dependent Apoptosis Pathway.
Yi C; Song M; Sun L; Si L; Yu D; Li B; Lu P; Wang W; Wang X
Oxid Med Cell Longev; 2022; 2022():3267450. PubMed ID: 35198095
[TBL] [Abstract][Full Text] [Related]
24. Activation of transient receptor potential vanilloid 4 exacerbates myocardial ischemia-reperfusion injury via JNK-CaMKII phosphorylation pathway in isolated mice hearts.
Zhang S; Lu K; Yang S; Wu Y; Liao J; Lu Y; Wu Q; Zhao N; Dong Q; Chen L; Du Y
Cell Calcium; 2021 Dec; 100():102483. PubMed ID: 34628110
[TBL] [Abstract][Full Text] [Related]
25. Tournefolic acid B, derived from Clinopodium chinense (Benth.) Kuntze, protects against myocardial ischemia/reperfusion injury by inhibiting endoplasmic reticulum stress-regulated apoptosis via PI3K/AKT pathways.
Yu Y; Xing N; Xu X; Zhu Y; Wang S; Sun G; Sun X
Phytomedicine; 2019 Jan; 52():178-186. PubMed ID: 30599897
[TBL] [Abstract][Full Text] [Related]
26. CaMKIIδ inhibition protects against myocardial ischemia/reperfusion injury: Role of Beclin-1-dependent autophagy.
Kong L; Xiong F; Sun N; Xu C; Chen Y; Yang J; Su X
Eur J Pharmacol; 2020 Nov; 886():173539. PubMed ID: 32918874
[TBL] [Abstract][Full Text] [Related]
27. Cardioprotection by CaMKII-deltaB is mediated by phosphorylation of heat shock factor 1 and subsequent expression of inducible heat shock protein 70.
Peng W; Zhang Y; Zheng M; Cheng H; Zhu W; Cao CM; Xiao RP
Circ Res; 2010 Jan; 106(1):102-10. PubMed ID: 19910575
[TBL] [Abstract][Full Text] [Related]
28. CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury.
Vila-Petroff M; Salas MA; Said M; Valverde CA; Sapia L; Portiansky E; Hajjar RJ; Kranias EG; Mundiña-Weilenmann C; Mattiazzi A
Cardiovasc Res; 2007 Mar; 73(4):689-98. PubMed ID: 17217936
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of the zinc transporter SLC39A13 (ZIP13) is responsible for the activation of CaMKII at reperfusion and leads to myocardial ischemia/reperfusion injury in mouse hearts.
Wang J; Cheng X; Zhao H; Yang Q; Xu Z
J Mol Cell Cardiol; 2021 Mar; 152():69-79. PubMed ID: 33307093
[TBL] [Abstract][Full Text] [Related]
30. Inhibitor 1 of Protein Phosphatase 1 Regulates Ca
Luo H; Song S; Chen Y; Xu M; Sun L; Meng G; Zhang W
Oxid Med Cell Longev; 2019; 2019():2193019. PubMed ID: 31885777
[TBL] [Abstract][Full Text] [Related]
31. Protective effects of echinacoside against anoxia/reperfusion injury in H9c2 cells via up-regulating p-AKT and SLC8A3.
Chen M; Wang X; Hu B; Zhou J; Wang X; Wei W; Zhou H
Biomed Pharmacother; 2018 Aug; 104():52-59. PubMed ID: 29763795
[TBL] [Abstract][Full Text] [Related]
32. Trimetazidine protects against myocardial ischemia/reperfusion injury by inhibiting excessive autophagy.
Wu S; Chang G; Gao L; Jiang D; Wang L; Li G; Luo X; Qin S; Guo X; Zhang D
J Mol Med (Berl); 2018 Aug; 96(8):791-806. PubMed ID: 29955901
[TBL] [Abstract][Full Text] [Related]
33. The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway.
Zhang X; Du Q; Yang Y; Wang J; Dou S; Liu C; Duan J
Biomed Pharmacother; 2017 Jul; 91():1042-1052. PubMed ID: 28525945
[TBL] [Abstract][Full Text] [Related]
34. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways.
Chen Y; Ba L; Huang W; Liu Y; Pan H; Mingyao E; Shi P; Wang Y; Li S; Qi H; Sun H; Cao Y
Eur J Pharmacol; 2017 Feb; 796():90-100. PubMed ID: 27916558
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor-C protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis.
Chen XG; Lv YX; Zhao D; Zhang L; Zheng F; Yang JY; Li XL; Wang L; Guo LY; Pan YM; Yan YW; Chen SY; Wang JN; Tang JM; Wan Y
Mol Cell Biochem; 2016 Feb; 413(1-2):9-23. PubMed ID: 26769665
[TBL] [Abstract][Full Text] [Related]
36. Clematichinenoside (AR) Attenuates Hypoxia/Reoxygenation-Induced H9c2 Cardiomyocyte Apoptosis via a Mitochondria-Mediated Signaling Pathway.
Ding H; Han R; Chen X; Fang W; Liu M; Wang X; Wei Q; Kodithuwakku ND; Li Y
Molecules; 2016 May; 21(6):. PubMed ID: 27248986
[TBL] [Abstract][Full Text] [Related]
37. MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarction.
Singh MV; Swaminathan PD; Luczak ED; Kutschke W; Weiss RM; Anderson ME
J Mol Cell Cardiol; 2012 May; 52(5):1135-44. PubMed ID: 22326848
[TBL] [Abstract][Full Text] [Related]
38. Tilianin improves cognition in a vascular dementia rodent model by targeting miR-193b-3p/CaM- and miR-152-3p/CaMKIIα-mediated inflammatory and apoptotic pathways.
Sun T; Tan L; Liu M; Zeng L; Zhao K; Cai Z; Sun S; Li Z; Liu R
Front Immunol; 2023; 14():1118808. PubMed ID: 37153565
[TBL] [Abstract][Full Text] [Related]
39. Shikonin protects H9C2 cardiomyocytes against hypoxia/reoxygenation injury through activation of PI3K/Akt signaling pathway.
Wang S; Zhu Y; Qiu R
Biomed Pharmacother; 2018 Aug; 104():712-717. PubMed ID: 29807220
[TBL] [Abstract][Full Text] [Related]
40. Ca2+/Calmodulin-Dependent Protein Kinase II Regulation by Inhibitor 1 of Protein Phosphatase 1 Protects Against Myocardial Ischemia-Reperfusion Injury.
Yu J; Chen Y; Xu M; Sun L; Luo H; Bao X; Meng G; Zhang W
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):460-473. PubMed ID: 31030549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
